Shopping Cart 0
Cart Subtotal
USD 0

Valeant Pharmaceuticals International, Inc.-Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 350

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 700

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 1050
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Valeant Pharmaceuticals International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary

Marketline's Valeant Pharmaceuticals International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Valeant Pharmaceuticals International, Inc. since January2007.

Synopsis

Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Valeant Pharmaceuticals International, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Valeant Pharmaceuticals International, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Valeant Pharmaceuticals International, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.

- Detailed reports of various financial transactions undertaken by Valeant Pharmaceuticals International, Inc. and its subsidiaries since 2007.

- Information about key financial and legal advisors for Valeant Pharmaceuticals International, Inc.'s financial deals transactions.

- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.

- Form an independent opinion about Valeant Pharmaceuticals International, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007.

- Track your competitors' business structure and growth strategies.

READ MORE

Table Of Content

Scope

Table of Contents

COMPANY OVERVIEW AND KEY FACTS 2

TABLE OF CONTENTS 5

LIST OF TABLES 6

LIST OF FIGURES 6

TARGETS AND PARTNERS 7

MERGERS & ACQUISITIONS 8

Mergers and Acquisitions - Overview 8

Mergers and Acquisitions - Deal reports 9

PARTNERSHIP 133

Partnership - Overview 133

Partnership - Deal reports 134

CAPITAL RAISING 299

Capital Raising - Deal reports 299

DIVESTMENTS 310

Divestments - Overview 310

Divestments - Deal reports 311

PRIVATE EQUITY & OWNERSHIP 324

Private Equity and Ownership - Deal reports 324

APPENDIX 328

Contact Us 328

About MarketLine Financial Deals Database 328

Deal Definition and Methodology 330

About MarketLine 337


List Of Figure

List of Figures

Figure 1: Valeant Pharmaceuticals International M&A volume and value trend (2014-YTD2018)

Figure 2: Valeant Pharmaceuticals International M&A activity by geography (2014-YTD2018)

Figure 3: Valeant Pharmaceuticals International partnership volume and value trend (2014-YTD2018)

Figure 4: Valeant Pharmaceuticals International partnership trend by key deal type (2014-YTD2018)

Figure 5: Valeant Pharmaceuticals International divestments volume and value trend (2014-YTD2018)

Figure 6: Valeant Pharmaceuticals International divestments by geography (2014-YTD2018)


List Of Table

List of Tables

Table 1: Valeant Pharmaceuticals International M&A volume and value trend (2014-YTD2018)

Table 2: Valeant Pharmaceuticals International M&A activity by geography (2014-YTD2018)

Table 3: Valeant Pharmaceuticals International partnership volume and value trend (2014-YTD2018)

Table 4: Valeant Pharmaceuticals International partnership trend by key deal type (2014-YTD2018)

Table 5: Valeant Pharmaceuticals International divestments volume and value trend (2014-YTD2018)

Table 6: Valeant Pharmaceuticals International divestments activity by geography (2014-YTD2018)

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com